Abstract
To improve the bioavailability of oleanolic acid (OA), OA-phospholipid complex (OA-PLC) was prepared and evaluated with solubility, differential scanning calorimetry, x-ray powder diffractometry, IR spectroscopy, dissolution study and pharmacokinetic characteristics in rats. Concentrations of OA after oral administration of OA-PLC and OA aqueous suspension in rats were determined by high-performance liquid chromatography/mass spectrometry /mass spectrometry. Solubility of OA-PLC in water and in n-octanol was effectively enhanced by 300 times and 1.2 times, respectively. Spectra of DSC, xRD and IR showed that OA-PLC was formed. Cmax of rats treated with OA and OA-PLC is 0.47 and 1.18 μg/mL, respectively. AUC0→24h and AUC0→∞ values in rats of group OA-PLC were increased significantly (p < 0.01) by 2.06 and 2.16 times compared with those of group OA, respectively. This study indicates the superiority of OA-PLC over OA, in terms of enhanced water and lipid solubility and improved bioavailability in rats.
Keywords: Fructus forsythiae, anti-nociceptive, Radix ginseng, Biopharmaceutics Classification System, Fructus ligustrilucidi, solid dispersion, drug-phospholipid complex, Caco-2 cell monolayers, bergenin, curcumin
Letters in Drug Design & Discovery
Title:Enhanced Oral Bioavailability of Oleanolic Acid in Rats with Phospholipid Complex
Volume: 9 Issue: 5
Author(s): Feng Cao, Yahan Gao, Zhi Yin, Qineng Ping
Affiliation:
Keywords: Fructus forsythiae, anti-nociceptive, Radix ginseng, Biopharmaceutics Classification System, Fructus ligustrilucidi, solid dispersion, drug-phospholipid complex, Caco-2 cell monolayers, bergenin, curcumin
Abstract: To improve the bioavailability of oleanolic acid (OA), OA-phospholipid complex (OA-PLC) was prepared and evaluated with solubility, differential scanning calorimetry, x-ray powder diffractometry, IR spectroscopy, dissolution study and pharmacokinetic characteristics in rats. Concentrations of OA after oral administration of OA-PLC and OA aqueous suspension in rats were determined by high-performance liquid chromatography/mass spectrometry /mass spectrometry. Solubility of OA-PLC in water and in n-octanol was effectively enhanced by 300 times and 1.2 times, respectively. Spectra of DSC, xRD and IR showed that OA-PLC was formed. Cmax of rats treated with OA and OA-PLC is 0.47 and 1.18 μg/mL, respectively. AUC0→24h and AUC0→∞ values in rats of group OA-PLC were increased significantly (p < 0.01) by 2.06 and 2.16 times compared with those of group OA, respectively. This study indicates the superiority of OA-PLC over OA, in terms of enhanced water and lipid solubility and improved bioavailability in rats.
Export Options
About this article
Cite this article as:
Feng Cao, Yahan Gao, Zhi Yin, Qineng Ping , Enhanced Oral Bioavailability of Oleanolic Acid in Rats with Phospholipid Complex, Letters in Drug Design & Discovery 2012; 9 (5) . https://dx.doi.org/10.2174/157018012800389340
DOI https://dx.doi.org/10.2174/157018012800389340 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biological Activities of Natural and Engineered Cyclotides, a Novel Molecular Scaffold for Peptide-Based Therapeutics
Current Molecular Pharmacology Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress
Current Proteomics Interaction and Structural Modification of Topoisomerase IIα by Peptidyl Prolyl Isomerase, pin1: An In Silico Study
Protein & Peptide Letters Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Detection of Diuretic Doping by Capillary Electrophoresis and Electrochemical Technology: A Mini-Review
Current Pharmaceutical Analysis Bispidine as a Privileged Scaffold
Current Topics in Medicinal Chemistry Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease
Central Nervous System Agents in Medicinal Chemistry Crystal Structure and Interaction of Phycocyanin with β-Secretase: A Putative Therapy for Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy
Current Cancer Drug Targets Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Current Drug Targets Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders
Mini-Reviews in Medicinal Chemistry The Pharmacogenomics “Side-effect” of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
Anti-Cancer Agents in Medicinal Chemistry Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology A Quantitative Structure-Activity Relationship Study on Some Imidazoles and 2-Aminopyridines Acting as Nitric Oxide Synthase (NOS) Inhibitors
Letters in Drug Design & Discovery Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry Nanotools for the Delivery of Antimicrobial Peptides
Current Drug Targets Nanomaterial Based Affinity Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for Biomolecules and Pathogenic Bacteria
Recent Patents on Nanotechnology Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives
Current Medicinal Chemistry Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease
Current Medicinal Chemistry AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
Current Pharmaceutical Design